Corcept Therapeutics CORT
NASDAQ CORT
$114.03 -1.21 (-1.05%)
As of: Oct 1, 2026 · 3:59 PM EDT

Corcept Therapeutics (CORT) Net Equity Issued and Repurchased (2011 - 2026)

Updated

Corcept Therapeutics (CORT) posted Net Equity Issued and Repurchased of $5.76 million for Q2 2026, down 37.7% from $9.24 million a year earlier but up 44.5% from the prior quarter.

Analysis

Corcept Therapeutics (CORT) Net Equity Issued and Repurchased (2011 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Equity Issued and Repurchased at Corcept Therapeutics was $14.64 million, up 6.1% year-over-year; for FY2025, it came in at $15.87 million, up 190.7% from FY2024.

  • Annual Net Equity Issued and Repurchased has increased for three consecutive years, though with a five-year compound annual growth rate of -7.3% (FY2020 to FY2025).
  • In prior years, Corcept Therapeutics' Net Equity Issued and Repurchased was $5.46 million in FY2024 (+42.4%), $3.83 million in FY2023 (+13.1%), $3.39 million in FY2022 (-79.1%) and $16.23 million in FY2021 (-30.1%).
  • Quarterly Net Equity Issued and Repurchased has run from a low of -$205,000 in Q4 2022 to a high of $9.24 million in Q2 2025 over five years.
  • On a year-over-year basis, Net Equity Issued and Repurchased increased in seven of the last eight quarters, with growth averaging 115.4%.
  • The strongest year-over-year quarter for Net Equity Issued and Repurchased in the past five years was Q2 2025, with growth of 443.9%; the weakest was Q2 2022, with a decline of 88.4%.
  • According to Business Quant data, Net Equity Issued and Repurchased for the three prior quarters was $3.98 million (Q1 2026), $2.86 million (Q4 2025) and $2.03 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Corcept Therapeutics 12.46 Bn 11.02 Bn 252.09 Mn 5.76 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.76 Mn
Mar 31, 2026 3.98 Mn
Dec 31, 2025 2.86 Mn
Sep 30, 2025 2.03 Mn
Jun 30, 2025 9.24 Mn
Mar 31, 2025 1.74 Mn
Dec 31, 2024 1.53 Mn
Sep 30, 2024 1.29 Mn
Jun 30, 2024 1.70 Mn
Mar 31, 2024 940,000.00
Dec 31, 2023 875,000.00
Sep 30, 2023 704,000.00
Jun 30, 2023 846,000.00
Mar 31, 2023 1.41 Mn
Dec 31, 2022 -205,000.00
Sep 30, 2022 1.66 Mn
Jun 30, 2022 550,000.00
Mar 31, 2022 1.38 Mn
Dec 31, 2021 3.05 Mn
Sep 30, 2021 4.40 Mn
API Access

Corcept Therapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CORT&period=max&api_key=YOUR_API_KEY